Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: An open-label pilot study

Letters in Applied Microbiology

Volumn 59, Issue 6, 2014, Pages 565-571

  Waki, N ^a   Matsumoto, M ^a   Fukui, Y ^a   Suganuma, H ^a  

^a KAGOME CO   (Japan)

Author keywords

Incidence; Influenza; Lactobacillus brevis KB290; Probiotics; Schoolchildren

Indexed keywords

PROBIOTICS;

COLONY FORMING UNITS; INCIDENCE; INFLUENZA; INTERVENTION STUDIES; LACTOBACILLUS BREVIS; LACTOBACILLUS BREVIS KB290; PILOT STUDIES; PROBIOTIC LACTOBACILLI; PROBIOTICS; SCHOOLCHILD;

BOTTLES;

PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; COLONY FORMING UNIT; COMMON COLD; DIETARY INTAKE; GASTROENTERITIS; HUMAN; INCIDENCE; INTERVENTION STUDY; LACTOBACILLUS BREVIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PILOT STUDY; SCHOOL CHILD; SEASONAL INFLUENZA; TREATMENT DURATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; INFLUENZA, HUMAN; MALE;

LACTOBACILLUS BREVIS;

CHILD; FEMALE; HUMANS; INCIDENCE; INFLUENZA, HUMAN; LACTOBACILLUS BREVIS; MALE; PILOT PROJECTS; PROBIOTICS;

EID: 84916934106     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/lam.12340     Document Type: Article

References (29)

1. Barik, S. (2012) New treatments for influenza. BMC Med 13, 104.
2. Davidson, L.E., Fiorino, A.M., Snydman, D.R. and Hibberd, P.L. (2011) Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 65, 501-507.
3. Fanning, S., Hall, L., Cronin, M., Zomer, A., MacSharry, J., Goulding, D., Motherway, M.O., Shanahan, F. et al. (2012) Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci USA 109, 2108-2113.
4. Fukui, Y., Sasaki, E., Fuke, N., Nakai, Y., Ishijima, T., Abe, K. and Yajima, N. (2013) Effect of Lactobacillus brevis KB290 on the cell-mediated cytotoxic activity of mouse splenocytes: a DNA microarray analysis. Br J Nutr 2, 1-13.
5. Fukui, Y., Sasaki, E., Fuke, N., Nakai, Y., Ishijima, T., Abe, K. and Yajima, N. (2014) Sequential gene expression profiling in the mouse spleen during 14 d feeding with Lactobacillus brevis KB290. Br J Nutr 28, 1-10.
6. Gasparini, R., Bonanni, P., Amicizia, D., Bella, A., Donatelli, I., Cristina, M.L., Panatto, D. and Lai, P.L. (2013) Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage. Hum Vaccin Immunother 9, 561-567.
7. Guillemard, E., Tondu, F., Lacoin, F. and Schrezenmeir, J. (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103, 58-68.
8. Kanda, Y. (2013) Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48, 452-458.
9. Kawai, S., Nanri, S., Ban, E., Inokuchi, M., Tanaka, T., Tokumura, M., Kimura, K. and Sugaya, N. (2011) Influenza vaccination of schoolchildren and influenza outbreaks in a school. Clin Infect Dis 53, 130-136.
10. Kishi, A., Uno, K., Matsubara, Y., Okuda, C. and Kishida, T. (1996) Effect of the oral administration of Lactobacillus brevis subsp. coagulans on interferon-alpha producing capacity in humans. J Am Coll Nutr 15, 408-412.
11. Lebeer, S., Claes, I.J., Verhoeven, T.L., Vanderleyden, J. and De Keersmaecker, S.C. (2011) Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol 4, 368-374.
12. Leyer, G.J., Li, S., Mubasher, M.E., Reifer, C. and Ouwehand, A.C. (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124, e172-e179.
13. Makino, S., Ikegami, S., Kano, H., Sashihara, T., Sugano, H., Horiuchi, H., Saito, T. and Oda, M. (2006) Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J Dairy Sci 89, 2873-2881.
14. Makino, S., Ikegami, S., Kume, A., Horiuchi, H., Sasaki, H. and Orii, N. (2010) Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr 104, 998-1006.
15. Matsumoto, K., Yamada, H., Takuma, N., Niino, H. and Sagesaka, Y.M. (2011) Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC Complement Altern Med 11, 15.
16. Merenstein, D., Murphy, M., Fokar, A., Hernandez, R.K., Park, H., Nsouli, H., Sanders, M.E., Davis, B.A. et al. (2010) Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 64, 669-677.
17. Murakami, K., Habukawa, C., Nobuta, Y., Moriguchi, N. and Takemura, T. (2012) The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial. Biopsychosoc Med 6, 16.
18. Nagai, T., Makino, S., Ikegami, S., Itoh, H. and Yamada, H. (2011) Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice. Int Immunopharmacol 11, 2246-2250.
19. Namba, K., Hatano, M., Yaeshima, T., Takase, M. and Suzuki, K. (2010) Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem 74, 939-945.
20. Neuzil, K.M., Dupont, W.D., Wright, P.F. and Edwards, K.M. (2001) Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20, 733-740.
21. Nobuta, Y., Inoue, T., Suzuki, S., Arakawa, C., Yakabe, T., Ogawa, M. and Yajima, N. (2009) The efficacy and the safety of Lactobacillus brevis KB290 as a human probiotics. Int J Probiotics Prebiotics 4, 263-270.
22. Olivares, M., Díaz-Ropero, M.P., Sierra, S., Lara-Villoslada, F., Fonollá, J., Navas, M., Rodríguez, J.M. and Xaus, J. (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254-260.
23. Sugaya, N., Nerome, K., Ishida, M., Matsumoto, M., Mitamura, K. and Nirasawa, M. (1994) Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 272, 1122-1126.
24. Suzuki, S., Yakabe, T., Suganuma, H., Fukao, M., Saito, T. and Yajima, N. (2013) Cell-bound exopolysaccharides of Lactobacillus brevis KB290: protective role and monosaccharide composition. Can J Microbiol 59, 549-555.
25. Tochigi Prefectural Infectious Disease Surveillance Centre. (2014) http://www.thec.pref.tochigi.lg.jp/tidc/data/data.htm (accessed 3 July 2014).
26. Ujike, M., Shimabukuro, K., Mochizuki, K., Obuchi, M., Kageyama, T., Shirakura, M., Kishida, N., Yamashita, K. et al. (2010) Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerg Infect Dis 16, 926-935.
27. Urashima, M., Segawa, T., Okazaki, M., Kurihara, M., Wada, Y. and Ida, H. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91, 1255-1260.
28. Vouloumanou, E.K., Makris, G.C., Karageorgopoulos, D.E. and Falagas, M.E. (2009) Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents 34, e1-e10.
29. Waki, N., Yajima, N., Suganuma, H., Buddle, B.M., Luo, D., Heiser, A. and Zheng, T. (2014) Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection. Lett Appl Microbiol 58, 87-93.